Mi-Hyang Han1, Jin Young Kang2, Hye Young Han1, Yun-Hwa Cho3, Dae-Hyun Jang4. 1. Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Dongsu-ro 56, Bupyeong-gu, Incheon, 21431, South Korea. 2. Seoul Asan Rehabilitation Clinic, Incheon, South Korea. 3. Korea Disabled people's Development Institute, Seoul, South Korea. 4. Department of Rehabilitation, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Dongsu-ro 56, Bupyeong-gu, Incheon, 21431, South Korea. dhjangmd@naver.com.
Abstract
PURPOSE: The aim of this study was to investigate the optimal age for starting cranial-remolding-orthosis therapy in children with deformational plagiocephaly. METHODS: Medical records of 310 patients with deformational plagiocephaly were retrospectively reviewed and the initial and final cranial vault asymmetry index (CVAI), age when starting therapy, duration of therapy, mean change of CVAI, improvement rate, and treatment success were analyzed. We compared outcomes according to the groups divided by ages starting therapy. RESULTS: There were no significant differences in improvement rate and duration of cranial-remolding-orthosis therapy among patients starting therapy at the age of 3, 4, and 5 months. However, when starting therapy after the age of 6 months, the rates of CVAI improvement were significantly lower and the duration of therapy was significantly increased. CONCLUSION: Considering the spontaneous resolution effect according to the head growth nature, the age 5 month is the optimal period to start cranial-remolding-orthosis therapy for deformational plagiocephaly.
PURPOSE: The aim of this study was to investigate the optimal age for starting cranial-remolding-orthosis therapy in children with deformational plagiocephaly. METHODS: Medical records of 310 patients with deformational plagiocephaly were retrospectively reviewed and the initial and final cranial vault asymmetry index (CVAI), age when starting therapy, duration of therapy, mean change of CVAI, improvement rate, and treatment success were analyzed. We compared outcomes according to the groups divided by ages starting therapy. RESULTS: There were no significant differences in improvement rate and duration of cranial-remolding-orthosis therapy among patients starting therapy at the age of 3, 4, and 5 months. However, when starting therapy after the age of 6 months, the rates of CVAI improvement were significantly lower and the duration of therapy was significantly increased. CONCLUSION: Considering the spontaneous resolution effect according to the head growth nature, the age 5 month is the optimal period to start cranial-remolding-orthosis therapy for deformational plagiocephaly.
Authors: Klaus W W Dörhage; Benedicta E Beck-Broichsitter; Vera von Grabe; Annalena Sonntag; Stephan T Becker; Jörg Wiltfang Journal: J Craniomaxillofac Surg Date: 2016-07-07 Impact factor: 2.078
Authors: John M Graham; Mayela Gomez; Andy Halberg; Dawn L Earl; Jeannie T Kreutzman; Jinrui Cui; Xiuqing Guo Journal: J Pediatr Date: 2005-02 Impact factor: 4.406
Authors: Robert P Lee; John F Teichgraeber; James E Baumgartner; Amy L Waller; Jeryl D English; Robert E Lasky; Charles C Miller; Jaime Gateno; James J Xia Journal: Cleft Palate Craniofac J Date: 2007-07-17
Authors: James T Thompson; Lisa R David; Benjamin Wood; Anne Argenta; Jordan Simpson; Louis C Argenta Journal: J Craniofac Surg Date: 2009-03 Impact factor: 1.046
Authors: Kevin M Kelly; Edward F Joganic; Stephen P Beals; Jeff A Riggs; Mary Kay McGuire; Timothy R Littlefield Journal: Glob Pediatr Health Date: 2018-10-16